Strip away the two largest venture checks ever written to AI companies and Q1 2026 tells a story the headline number hides. Generative AI attracted $145 billion in venture capital last quarter — a record, according to S&P Global Market Intelligence — but $142 billion of that went to two companies. The remaining $3 billion, spread across hundreds of startups, is the figure that frames where the market actually stands.
OpenAI closed a $122 billion round in February with Amazon, Nvidia, and SoftBank as participants. xAI secured $20 billion in January. Both rounds are historically large by any measure. Both compress what would otherwise look like a broad-based boom into a story about extreme concentration at the top of the market.
Reading the OpenAI Valuation
At its reported post-money valuation, OpenAI ranks among the most valuable corporations on the planet — in the same range as Apple and Saudi Aramco. That puts a significant burden of proof on the revenue trajectory. The bull case is that OpenAI’s annual recurring revenue, which has been growing at triple-digit rates, will catch up to the multiple inside 24 months, making the entry price defensible. The bear case is that the round was priced at peak enthusiasm and that LP capital will not get paid back at the promised return.
Amazon’s participation is notable beyond the dollar amount. AWS has committed up to $4 billion to Anthropic and built substantial distribution infrastructure around that relationship. Joining the OpenAI round introduces a direct conflict — or, depending on perspective, a hedge. The cloud business has found itself in this dual-track position across its most important customer categories, and AI is no exception.
Where the $3 Billion Went
The venture market outside the megadeals is active but priced differently than a year ago. Seed-stage AI valuations in March 2026 ran 18% below the March 2025 median, per S&P Global data. The compression reflects investor judgment about which layer of the stack has already picked winners. At the foundation model level, that judgment is binary: the money went to OpenAI and xAI. Everything else is a feature risk.
The applied layer is a different picture. Vertical AI companies targeting healthcare administration, legal document processing, and financial services compliance are drawing Series A and B rounds in the $50 million to $200 million range at valuations that look sustainable relative to their revenue. These companies run on enterprise SaaS economics — annual contracts, high retention, compounding net revenue retention — at roughly twice the growth velocity the SaaS cohort achieved from 2018 to 2022. The investor base backing them is, in many cases, the same one that ran those earlier cycles.
The Talent Problem at Series B
Capital is available for the right applied AI company. What is not easily available is the engineering talent required to build. OpenAI and xAI, flush with Q1 capital, are offering compensation packages — cash plus meaningful equity on enormous post-money cap tables — that are difficult to match at the Series B stage. Founders are responding with creative structures: founder-equivalent share grants, accelerated vesting, and cash-heavy bases. The math holds if revenue compounds as projected. Companies that miss their targets will reprice at the next round, and that repricing will happen quickly once the data is in.
The record Q1 number will almost certainly not repeat in Q2. Megadeals of the OpenAI and xAI scale do not close on a quarterly cadence. What will persist is the applied market, which is where the long-term durability of AI investment — and the returns that come with it — will be determined.
Source: Generative AI Pulled In a Record $145 Billion in Q1 Venture Capital
